# Observational Study for the Evaluation of the Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV Reservoir

> **NCT04263207** · — · SUSPENDED · sponsor: **Barbara Ensoli, MD, PhD** · enrollment: 100 (estimated)

## Conditions studied

- HIV/AIDS

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT04263207
- **Lead sponsor:** Barbara Ensoli, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-02-04
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** Study halted prematurely due to the difficulties in dedicating the human resources necessary to conduct the study deriving from the COVID-19 pandemic, but potentially will resume
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04263207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04263207, "Observational Study for the Evaluation of the Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV Reservoir". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04263207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*